Status:
COMPLETED
A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold
Lead Sponsor:
Hyben Vital ApS
Conditions:
Flu
Common Cold
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
The trial is an investigator-initiated, double-blind, randomized, placebo-controlled phase III study. After the patient has receiving information about the study and after given written informed cons...
Eligibility Criteria
Inclusion
- First Men and women aged 50 + years
- It is accepted that the subjects can be treated for medical diseases.
- It is also accepted that the subjects receiving daily medication such as diuretics and medication for Hypertension, hypercholesterolemia and blood glucose-lowering treatment, medicine that strengthens the heart, symptom-relieving medication for joint disease, etc.
- Subjects may also use n-3 fatty acids (fish oil), as long as the fixed dosage.
Exclusion
- Subjects who have been treated with rose hip extracts or powder within 3 months before screening.
- Subjects who have been treated with ginger, avocado / soy, large doses of vitamins (including vitamin C) or other known dietary supplements within 3 months before screening
- Subjects that have been deemed to be have a hard time collaboration
- Subjects who abuse narcotics.
- Subjects who abuse alcohol
- Subjects with a current mental illness
- Subjects with known allergy to rose hips
- Subjects participating in another clinical trial, or have participated in another clinical trial within 3 months before this trial started.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01459952
Start Date
November 1 2011
End Date
May 1 2012
Last Update
June 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Frederiksberg University Hospital
Frederiksberg, Denmark, 2000